Is Bio-Rad a good company?

Out of 63 Bio-Rad Laboratories employee reviews, 64% were positive. The Engineering team, with 67% positive reviews, reports the best experience at Bio-Rad Laboratories compared to all other departments at the company.

How do you cite Bio-Rad?

To cite bioRad in publications, please use: Dokter AM, Desmet P, Spaaks JH, Van Hoey S, Veen L, Verlinden L, Nilsson C, Haase G, Leijnse H, Farnsworth A, Bouten W, Shamoun-Baranes J (2019). “bioRad: biological analysis and visualization of weather radar data.” Ecography, 42, 852-860.

Who owns Bio-Rad?

Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets….Bio-Rad Laboratories.

Type Public
Number of employees 8,120 (2019)
Footnotes / references

Is Bio-Rad a biotech company?

About Bio-Rad Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.

Who are Bio-Rad competitors?

Bio-Rad Laboratories competitors include Agilent Technologies, Roche and Danaher.

What does Bio-Rad Lab do?

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components.

Is Bio-Rad a buy?

Bio-Rad Laboratories has received a consensus rating of Buy.

Why is Bio-Rad stock dropping?

Shares in Bio-Rad dropped 16.8 percent for the five-day trading period ended Tuesday. The firm’s shares took a hit due to an underwhelming financial forecast during its fourth-quarter conference call last week (see related article, this issue), and a drop in stocks across the board.

What does Bio-Rad do?

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare.

Is Bio a buy?

Bio-Rad Laboratories currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.

Is Bio-Rad undervalued?

At this time, the firm appears to be undervalued. Our model approximates the value of Bio-Rad Laboratories from analyzing the firm fundamentals such as Return On Equity of 48.49 %, current valuation of 17.36 B, and Profit Margin of 151.73 % as well as examining its technical indicators and Probability Of Bankruptcy.

Why is Bio-Rad stock falling?